| Data Evaluation |
Policy 18 |
| About SWOG |
| History |
Southwest Oncology Group History (9/2007) |
| |
| Manuals |
| CRA Manual |
CRA Manual (1/2008) |
| Nursing Committee Manual |
Nursing Committee Manual (4/2009) |
| |
| Policies |
| Policy 01 |
Southwest Oncology Group Mission Statement (5/2007) |
| Policy 02 |
Constitution/ByLaws (4/2009) |
| Policy 03 |
Guidelines for Full Group Institutional Members (5/2008) |
| Policy 04 |
Community Clinical Oncology Program Guidelines (5/2008) |
| Policy 05 |
Affiliate Program Membership (5/2008) |
| Policy 07 |
New Investigator Nomination Process (4/2004) |
| Policy 08 |
Committee Membership Nominations (4/2003) |
| Policy 09 |
Investigator/Clinical Research Associate/Nurse Contribution Sheets
(4/2006) |
| Policy 10 |
Job Description/Disease Committee Chair (4/2009) |
| Policy 11 |
Job Description/Study Coordinator (4/2006) |
| Policy 12 |
Southwest Oncology Group Registration and
Treatment (5/2008) |
| Policy 13 |
Protocol Guidelines (4/2009) |
| Policy 14 |
Conduct of Intergroup Trials (Revisions Pending NCI Guidelines Update) |
| Policy 15 |
Group Protocols Sponsored by Pharmaceutical
Companies/IND Applications (5/2008) |
| Policy 16 |
Policy Deleted (no download available) |
| Policy 17 |
Cost Containment (5/2007) |
| Policy 18 |
Data Evaluation Policy and Procedures |
| Policy 19 |
Quality Assurance Program (4/2009) |
| Policy 20 |
New Agent Studies and Safety Monitoring (4/1997) |
| Policy 21 |
Data and Safety Monitoring (11/2008) |
| Policy 22 |
Ethical and Regulatory Considerations (4/2002) |
| Policy 23 |
Serious Adverse Events (4/2009) |
| Policy 24 |
Procedural Guidelines for Publication (11/2008) |
| Policy 25 |
Drug Ordering (4/2009) |
| Policy 26 |
Radiation Therapy Quality Assurance Committee (4/2005) |
| Policy 27 |
Bone Marrow and Stem Cell Transplantation Guidelines for Institution Approval (4/2004) |
| Policy 28 |
Guidelines for the Conduct of "Developmental Strategy Review", Review of Correlative Science and
Pilot Protocols
(4/2006) |
| Policy 29 |
Roster of Investigators Maintenance Policies and
Procedures (4/2003) |
| Policy 30 |
Responsibility for Patient Follow-Up (04/2009) |
| Policy 31 |
HIPAA Privacy Rule Policy (4/2004) |
| Policy 32 |
Conduct of Non-Therapeutic Studies (1/1994) |
| Policy 33 |
Institutional Performance Review (5/2007) |
| Policy 34 |
Industrial Interaction (5/2007) |
| Policy 35 |
Conflict of Interest and Financial/Affiliation Declaration Form (10/2008) |
| Policy 36 |
Affirmation of Integrity (9/2005) |
| Policy 37 |
Certification of Education in the Protection of Human Subjects (7/2006) |
| Policy 38 |
Dosing Principles for Patients on Clinical Trials (4/2009) |
| Policy 39 |
Acquisition, Maintenance and Use in Research of Tissue and Other Biologic Patient Specimens (5/2007) |
| Policy 40 |
Membership of Non-United States Institutions (4/2009) |
| Policy 41 |
Debarment, Suspension or Other Administrative Actions & Handling of Allegations of Research Misconduct (9/2005) |
| Policy 42 |
Advertising for Subject Recruitment (5/2007) |
| Policy 43 |
Requests for Patient Data from Investigators and Pharmaceutical Companies (4/2006) |
| Policy 44 |
Early Closure of Studies (10/2007) |
